Dr. Sean Quinn is a postdoctoral fellow at the Children’s Hospital of Philadelphia in the laboratory of Dr. Rodney Camire. Dr. Quinn received his doctoral degree in Biochemistry/Biophysics from Rensselaer Polytechnic Institute in 2019. For his JGP…
FOR IMMEDIATE RELEASE
Media Contact
Ilana Ostrin
iostrin@hemophilia.org
212-328-3769
NHF Awarded NIH Grant for State of the Science Research Summit
Additional Funding Will Aid Community Collaboration at First-Time Event
New York, NY —…
Objective:
Acute bleeds in patients with rare bleeding disorders (RBDs), including congenital hemophilia with inhibitors (CHwI), acquired hemophilia, congenital factor VII deficiency, and Glanzmann’s thrombasthenia (GT) must be…
Honor Jason's legacy by ensuring tomorrow's young leaders can access real-world opportunities through NYLI. Driven and vibrant, Jason pursued a rich, meaningful life, despite complications from his hemophilia diagnosis and treatment. Jason's memory…
Honor Jason's legacy by ensuring tomorrow's young leaders can access real-world opportunities through NYLI. Driven and vibrant, Jason pursued a rich, meaningful life, despite complications from his hemophilia diagnosis and treatment. Jason's memory…
Named in honor of Dr. Judith Graham Pool, NBDF's premier research fellowship program provides support for basic science and pre-clinical bleeding disorders research. JGP Fellows, whose work is made possible by generous donors like you, improve care…
Adam Lynch was a loyal friend, an original thinker, and a clever writer whose life was cut short by a bleeding disorder. Created to celebrate Adam's drive, this scholarship awards like-minded young community members (affected directly or indirectly…
Your gift, no matter the size, provides critical support to the inheritable blood disorders community. From researching better treatment options, to advocating for quality healthcare, to creating tailored educational events, NBDF’s work for this…
Objective:
Immune tolerance induction (ITI) is the standard of care for inhibitor eradication and restoration of factor VIII (FVIII) responsiveness in subjects with severe hemophilia who develop high-titer inhibitors.…
.flip-card {
background-color: transparent;
min-width: 100%;
height:500px;
perspective: 1000px;
}
.flip-card-inner {
position: relative;
width: 100%;
height: 100%;
text-align: center;
transition: transform 0.6s;…